ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaKyowa Kirin Sàrl
Kyowa Kirin Sàrl Logo
Verified· 2 sources

Kyowa Kirin Sàrl

Summary

About the company

The core activity of Krystal Biotech, Inc. is the development and manufacture of pharmaceuticals, particularly biopharmaceuticals. The company focuses on the research and development of new therapeutics based on genetic and biotechnological methods. The company's products aim to treat various diseases and conditions, including rare genetic disorders.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered7
Gene Therapy for Dystrophic Epidermolysis Bullosa (VYJUVEK)
Gene therapy for dystrophic epidermolysis bullosa with VYJUVEK, the first and only redosable gene therapy for this disease, plus personalized patient support.
Gene Therapy Platform
Gene therapy platform based on a modified HSV-1 vector for redosable, non- or minimally invasive administration; supports development and commercialization of genetic medicines.
Oncology Gene Therapies
Oncology gene therapies with locally delivered immune-stimulating cytokines; a lead candidate uses a modified HSV-1 vector to deliver IL-12 and IL-2 to solid tumors.
Gene Therapies for Respiratory Diseases
Gene therapies for cystic fibrosis and alpha-1 antitrypsin deficiency, developed for pulmonary use in genetic diseases with high unmet need.
Gene Therapies for Ophthalmic Diseases
Gene therapies for ocular complications of dystrophic epidermolysis bullosa and other genetic eye diseases such as Stargardt disease.
Gene Therapies for Dermatologic Diseases
Gene therapies for genetic skin diseases such as autosomal recessive congenital ichthyosis and Netherton syndrome, complementing the approved skin platform.
Aesthetic Gene Therapies
Aesthetic gene therapies for age-related skin changes through targeted delivery of genes that boost collagen and elastin expression.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Comparisons

Kyowa Kirin Sàrl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Kyowa Kirin Sàrl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Kyowa Kirin Sàrl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Place des Alpes 4
1201 Geneva

At a glance

Legal form
Limited Liability Company
UID
CHE-350.938.341
Founded
2016 · 10 years
Last commercial register change
March 18, 2026
Employees
21 to 50

Knowledge

No knowledge articles yet

Once Kyowa Kirin Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

AS
Ageronix SA
Carouge Ge
CR
CELL RECEPTOR SA
Geneva
UF
Union for International Cancer Control (UICC)
Geneva
NS
NovImmune SA
Plan-Les-Ouates
IS
iOnctura SA
Geneva
SG
SANOFI GESTION SA
Vernier
SS
Skinpulse SARL
Geneva
MT
MPC Therapeutics SA
Geneva